Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round. The company develops monoclonal antibodies for oral administration to en
ViroVet nv, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that it has successfully confirmed t
Recognition of Biotalys' unique protein-based biocontrol solutions for food protection.
Strenghtening Executive Management Team with international financial leadership